TickerFacts.

Vivos Therapeutics, Inc. (VVOS): Long-Term Debt

Annual figures by period end, from SEC filings.

$753.0K
As of 2025-12-31
$582.0K
As of 2026-06-30
-10.2%
5-year compound annual growth
$3.71M2019-12-31: $3.71M2020-12-31: $1.29M2021-12-31: $1.26M2025-12-31: $753.0K$753.0K
2019-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$753.0Kn/a2026-04-15, Balance as of period end
No annual figure between 2021-12-31 and 2025-12-31.
2021-12-31$1.26M-1.9%2022-03-31, Balance as of period end
2020-12-31$1.29M-65.2%2022-03-31, Balance as of period end
2019-12-31$3.71Mn/a2021-03-25, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Vivos Therapeutics, Inc. (VVOS)2025-12-31$753.0Kn/a
Profound Medical Corp. (PROF)2025-12-31$4.50M-3.5%
Spectral AI, Inc. (MDAI)2025-12-31$9.25Mn/a
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$8.72M+96.0%
Nexgel, Inc. (NXGL)2025-12-31$588.0K-14.2%
Premier Air Charter Holdings Inc. (PREM)2025-12-31$485.7Kn/a
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$15.00M0.0%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$49.08Mn/a
Retractable Technologies Inc (RVP)2025-12-31$895.6K-27.3%

Compare VVOS, PROF, MDAI, BDMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗